You have 9 free searches left this month | for more free features.

Condition

Adult Giant Cell Glioblastoma (1)

Adult Glioblastoma (1)

Adult Gliosarcoma (1)

Hepatocellular Carcinoma (1)

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Abramson Cancer Center of the University of Pennsylvania (1)

National Cancer Institute (NCI) (1)

University of Alabama at Birmingham (1)

Collaborator

Intervention

fmiso (3)

mri (1)

mrs (1)

nelfinavir (viracept®) 1250 mg (1)

pet (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

fmiso

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatocellular Carcinoma Trial in Birmingham (FMISO)

Terminated

Hepatocellular Carcinoma

FMISO

Birmingham, Alabama

UAB Advanced Imaging Facility

Feb 15, 2021

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

Active, not recruiting

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx

Nelfinavir (Viracept®) 1250 mg
FMISO

Philadelphia, Pennsylvania

Abramson Cancer Center of the University of Pennsylvania

Jun 30, 2021

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (FMISO, MRI, PET)

Completed

Adult Giant Cell Glioblastoma
+2 more

FMISO
+3 more

Birmingham, Alabama
+13 more

Mar 14, 2019